Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis

NCT00963703 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Rituximab

Sponsor

University of Manitoba

Collaborators

[object Object]